Top

Breast Cancer Research and Treatment

Published in:

01-02-2021 | Breast Cancer | Epidemiology

Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey

Authors: Anand K. Narayan, Sarah F. Mercaldo, Yasha P. Gupta, Erica T. Warner, Constance D. Lehman, Randy C. Miles

Published in: Breast Cancer Research and Treatment | Issue 1/2021

Abstract

Purpose

Mammography screening encounters may represent ideal opportunities to identify high-risk women for risk-based screening. During mammography appointments, radiology practices evaluate breast density and ascertain known breast cancer risk factors. Our purpose was to evaluate the potential for mammographic screening encounters to identify high-risk women by estimating the (1) proportion of high-risk women who report that they have undergone mammographic screening and the (2) proportion of high-risk women who receive recommendations for breast MRI screening.

Methods

Women ages 30–85 without breast cancer histories were included from the 2015 National Health Interview Survey, a nationally representative cross-sectional household survey (response rate 80%). Breast Cancer Risk Assessment Tool was used to determine high-risk (lifetime risk>20%). Among high-risk women, primary outcome was proportion reporting mammography screening, secondary outcome was receipt of a breast MRI recommendation after recent mammogram, accounting for complex survey design.

Results

14,958 women were included. 1.0% were high-risk of whom: 91.9% ever had a mammogram, 68.0% had a mammogram within the last year, 81.5% had a mammogram within the last 2 years. 6.4% were recommended to undergo breast MRI. Among high-risk women, women with dense breast tissue were more likely (OR 496.0, 95%CI 52.6,4674.0) and older women were less likely (OR 0.91, 95%CI 0.84,0.99) to receive recommendations for breast MRI.

Conclusions

Among high-risk women, 92% reported undergoing at least one mammogram in their lives. 94% did not receive recommendations for breast MRI screening and 32% did not have a mammogram within the last year. To identify high-risk women, breast imaging centers should consider determining lifetime breast cancer risk during mammography screening visits.

Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835. https://doi.org/10.1097/EDE.0b013e3181577511CrossRefPubMed

NHIS. About the National Health Interview Survey. Available at: https://www.cdc.gov/nchs/nhis/about_nhis.htm. Published July 11, 2017. Accessed 2 July 2020

Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography [published correction appears in CA Cancer J Clin. May-Jun;57(3):185]. CA Cancer J Clin 57(2):75–89. https://doi.org/10.3322/canjclin.57.2.75CrossRefPubMed

Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886CrossRef

Schenker N, Raghunathan TE, Chiu PL, Makuc DM, Zhang G, Cohen AJ (2006) Multiple imputation of missing income data in the National Health Interview Survey. J Am Stat Assoc 101:924–933CrossRef

Mandelblatt JS, Stout NK, Schechter CB et al (2016) Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies. Ann Intern Med 164(4):215–225. https://doi.org/10.7326/M15-1536CrossRefPubMedPubMedCentral

Jiang X, McGuinness JE, Sin M, Silverman T, Kukafka R, Crew KD (2019) Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report. JCO Clin Cancer Inform (3):1–8. https://doi.org/10.1200/CCI.18.00072

Eden KB, Ivlev I, Bensching KL et al (2020) Use of an online breast cancer risk assessment and patient decision aid in primary care practices. J Womens Health (Larchmt) 29(6):763–769. https://doi.org/10.1089/jwh.2019.8143CrossRef

Boyd NF, Guo H, Martin LJ et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236. https://doi.org/10.1056/NEJMoa062790CrossRefPubMed

10.

Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005) Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94(2):115–122. https://doi.org/10.1007/s10549-005-5152-4CrossRefPubMed

11.

Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R (2019) A deep learning mammography-based model for improved breast cancer risk prediction. Radiology 292(1):60–66. https://doi.org/10.1148/radiol.2019182716CrossRefPubMed

12.

Wernli KJ, DeMartini WB, Ichikawa L et al (2014) Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med 174(1):125–132. https://doi.org/10.1001/jamainternmed.2013.11963CrossRefPubMedPubMedCentral

13.

Miles R, Wan F, Onega TL et al (2018) Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Womens Health (Larchmt) 27(6):748–754. https://doi.org/10.1089/jwh.2017.6623CrossRef

14.

Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR (2015) Prospective approach to breast cancer risk prediction in African American women: the black women’s health study model. J Clin Oncol 33(9):1038–1044. https://doi.org/10.1200/JCO.2014.57.2750CrossRefPubMedPubMedCentral

15.

Jones T, McCarthy AM, Kim Y, Armstrong K (2017) Predictors of BRCA1/2 genetic testing among black women with breast cancer: a population-based study. Cancer Med 6(7):1787–1798. https://doi.org/10.1002/cam4.1120CrossRefPubMedPubMedCentral

16.

Narayan A, Fischer A, Zhang Z, Woods R, Morris E, Harvey S (2017) Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results. Breast Cancer Res Treat 164(3):719–725. https://doi.org/10.1007/s10549-017-4286-5CrossRefPubMed

17.

Siu AL (2016) U.S. preventive services task force. Screening for breast cancer: U.S. preventive services task force recommendation statement [published correction appears in Ann Intern Med. Mar 15;164(6):448]. Ann Intern Med 164(4):279–296. https://doi.org/10.7326/M15-2886CrossRefPubMed

18.

ASBrS releases position statement on screening mammography [news release]. The American Society of Breast Surgeons website; May 3, 2019. https://www.breastsurgeons.org/news/?id=23. Accessed 10 July 2020

19.

Sirovich BE, Welch HG (2004) The frequency of pap smear screening in the United States. J Gen Intern Med 19(3):243–250. https://doi.org/10.1111/j.1525-1497.2004.21107.xCrossRefPubMedPubMedCentral

20.

Newman LA (2005 Jan) Breast cancer in African-American women. Oncologist 10(1):1–14CrossRef

21.

Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21(4):593–601. https://doi.org/10.1200/JCO.2003.07.007CrossRefPubMed

22.

Gordon NP, Hiatt RA, Lampert DI (1993) Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 85(7):566–570. https://doi.org/10.1093/jnci/85.7.566CrossRefPubMed

23.

Miller JW, Sabatino SA, Thompson TD et al (2013) Breast MRI use uncommon among U.S. women. Cancer Epidemiol Biomark Prev 22(1):159–166. https://doi.org/10.1158/1055-9965.EPI-12-0967CrossRef

Title: Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey
Authors: Anand K. Narayan
Sarah F. Mercaldo
Yasha P. Gupta
Erica T. Warner
Constance D. Lehman
Randy C. Miles
Publication date: 01-02-2021
Publisher: Springer US
Keywords: Breast Cancer
Mammography
Breast Cancer
Breast MRI
Mammography
Published in: Breast Cancer Research and Treatment / Issue 1/2021
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-020-06002-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Letter to the Editor regarding the publication titled “Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?”

Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?

Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population

The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer

ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes

HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer